Drugging PI3K in cancer: refining targets and therapeutic strategies
Author:
Funder
Cancer Research UK
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference81 articles.
1. Drugging the PI3 kinome;Workman;Nat Biotechnol,2006
2. Phosphatidylinositide-3-kinase inhibitors: addressing questions of isoform selectivity and pharmacodynamic/predictive biomarkers in early clinical trials;Clarke;J Clin Oncol,2012
3. What a tangled web we weave: emerging resistance mechanisms to inhibition of the phosphoinositide 3-kinase pathway;Klempner;Cancer Discov,2013
4. Sanger Institute Cosmic database. http://www.sanger.ac.uk/genetics/CGP/cosmic/.
5. High frequency of mutations of the PIK3CA gene in human cancers;Samuels;Science,2004
Cited by 185 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. From lab to clinic: The discovery and optimization journey of PI3K inhibitors;European Journal of Medicinal Chemistry;2024-11
2. Selective regulation of chemosensitivity in glioblastoma by phosphatidylinositol 3-kinase beta;iScience;2024-06
3. The state of the art in secondary pharmacology and its impact on the safety of new medicines;Nature Reviews Drug Discovery;2024-05-21
4. Inhibition of PI3K/AKT signaling using BKM120 reduced the proliferation and migration potentials of colorectal cancer cells and enhanced cisplatin-induced cytotoxicity;Molecular Biology Reports;2024-03-14
5. Design, synthesis, molecular modelling and biological evaluation of novel 6-amino-5-cyano-2-thiopyrimidine derivatives as potent anticancer agents against leukemia and apoptotic inducers;Journal of Enzyme Inhibition and Medicinal Chemistry;2024-02-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3